Breaking News Instant updates and real-time market news.

BCLI

BrainStorm

$3.92

0.15 (3.98%)

04:55
02/14/19
02/14
04:55
02/14/19
04:55

BrainStorm management to meet with Maxim

Meetings to be held in New York February 13-14 hosted by Maxim.

  • 14

    Feb

BCLI BrainStorm
$3.92

0.15 (3.98%)

05/15/18
HCWC
05/15/18
INITIATION
Target $11
HCWC
Buy
BrainStorm initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert initiated BrainStorm with a Buy and $11 price target saying it is developing a first of its kind cell therapy, called NurOwn, for the treatment of Amyotrophic Lateral Sclerosis, or ALS. Kolbert said NurOwn has an established clean safety profile and convenient dosing, but also has the potential to be disease modifying, slowing down disease progression. This, combined with orphan status for a 30K U.S. and 55K EU patient market, establish real value in the company.
06/26/18
HCWC
06/26/18
NO CHANGE
Target $11
HCWC
Buy
BrainStorm 'distressed' valuation an opportunity, says H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert noted that Brainstorm announced that it will not make NurOwn available under the newly enacted "Right to Try" Act. Management deemed this impractical since the unapproved ALS treatment would only be available to those who can afford it, which would be unethical. The focus must be on completing the clinical program so the therapy can be made available to all with reimbursement, said Kolbert, who thinks Brainstorm's current valuation is "distressed" at a market capitalization below $100M despite its lead program being in a pivotal trial. He maintains a Buy rating and $11 price target on Brainstorm shares.
10/29/18
HCWC
10/29/18
NO CHANGE
Target $11
HCWC
Buy
BrainStorm's 'distressed valuation' presents opportunity, says H.C. Wainwright
After BrainStorm Cell Therapeutics reported that it spent "just" $3.2M in the third quarter and management reiterated that they continue to anticipate the ALS pivotal trial enrollment is on track to complete by mid-2019, H.C. Wainwright analyst Jason Kolbert said he view's Brainstorm's current valuation as "distressed" given NurOwn's clean safety profile and the fact that it is in a pivotal trial. Applying a 70% probability of success, he maintains a Buy rating and $11 price target on BrainStorm shares.

TODAY'S FREE FLY STORIES

10:35
02/20/19
02/20
10:35
02/20/19
10:35
Conference/Events
Morgan Stanley sports/footwear analyst to hold analyst/industry conference call »

Sports & Footwear…

KO

Coca-Cola

$44.99

0.17 (0.38%)

10:30
02/20/19
02/20
10:30
02/20/19
10:30
Options
Vote of confidence in Coca Cola »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

ARW

Arrow Electronics

$81.74

0.73 (0.90%)

10:28
02/20/19
02/20
10:28
02/20/19
10:28
Hot Stocks
Arrow Electronics CEO sells over $4.3M worth of shares »

Arrow Electronics CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

10:25
02/20/19
02/20
10:25
02/20/19
10:25
Conference/Events
Credit Suisse analysts to hold an analyst/industry conference call »

Analysts discuss the HOLT…

10:25
02/20/19
02/20
10:25
02/20/19
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

FLR

Fluor

$37.46

0.46 (1.24%)

, HAL

Halliburton

$32.29

0.59 (1.86%)

10:21
02/20/19
02/20
10:21
02/20/19
10:21
Hot Stocks
Fluor awarded Halliburton chemicals project in Saudi Arabia »

Fluor (FLR) announced…

FLR

Fluor

$37.46

0.46 (1.24%)

HAL

Halliburton

$32.29

0.59 (1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 15

    May

  • 22

    May

  • 28

    May

W

Wayfair

$120.90

0.67 (0.56%)

10:20
02/20/19
02/20
10:20
02/20/19
10:20
Hot Stocks
Hedgeye names Wayfair as new short idea »

Hedgeye named Wayfair as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

TSLA

Tesla

$304.20

-1.36 (-0.45%)

10:20
02/20/19
02/20
10:20
02/20/19
10:20
Options
Put buyers in Tesla weekly options »

Put buyers in Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

IRM

Iron Mountain

$35.51

0.12 (0.34%)

10:18
02/20/19
02/20
10:18
02/20/19
10:18
Recommendations
Iron Mountain analyst commentary  »

Iron Mountain price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
02/20/19
02/20
10:17
02/20/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$306.68

1.33 (0.44%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Hot Stocks
Humana, PatientPing announce agreement to improve care coordination »

PatientPing announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 19

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOD

Kodiak Sciences

$7.51

0.64 (9.32%)

, VEEV

Veeva

$120.49

0.1 (0.08%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

KOD

Kodiak Sciences

$7.51

0.64 (9.32%)

VEEV

Veeva

$120.49

0.1 (0.08%)

AGIO

Agios Pharmaceuticals

$58.78

1.07 (1.85%)

KIDS

OrthoPediatrics

$38.69

1.31 (3.50%)

FIXX

Homology Medicines

$24.90

0.87 (3.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 13

    Mar

  • 26

    Mar

  • 27

    Mar

  • 10

    Apr

  • 11

    Apr

  • 21

    Jun

CVS

CVS Health

$63.82

-6.1 (-8.72%)

, LUV

Southwest

$54.63

-3.03 (-5.25%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CVS

CVS Health

$63.82

-6.1 (-8.72%)

LUV

Southwest

$54.63

-3.03 (-5.25%)

SCHW

Charles Schwab

$45.95

-1.11 (-2.36%)

ETFC

E-Trade

$48.05

-0.61 (-1.25%)

PANW

Palo Alto Networks

$228.77

-1.42 (-0.62%)

TEVA

Teva

$17.40

-0.61 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 04

    Mar

  • 05

    Mar

  • 12

    Mar

IPSEY

Ipsen

$0.00

(0.00%)

, CS

Credit Suisse

$11.91

0.005 (0.04%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

IPSEY

Ipsen

$0.00

(0.00%)

CS

Credit Suisse

$11.91

0.005 (0.04%)

AXL

American Axle

$16.92

0.32 (1.93%)

DO

Diamond Offshore

$10.65

0.36 (3.50%)

RIG

Transocean

$8.86

0.12 (1.37%)

PFE

Pfizer

$42.25

-0.33 (-0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 18

    May

  • 22

    May

LUV

Southwest

$54.67

-2.99 (-5.19%)

, ALK

Alaska Air

$63.60

-0.95 (-1.47%)

10:15
02/20/19
02/20
10:15
02/20/19
10:15
On The Fly
Goldman Sachs says sell Southwest as airline cuts guidance »

Shares of Southwest (LUV)…

LUV

Southwest

$54.67

-2.99 (-5.19%)

ALK

Alaska Air

$63.60

-0.95 (-1.47%)

AAL

American Airlines

$34.96

-0.5 (-1.41%)

UAL

United Continental

$87.68

-1.53 (-1.72%)

DAL

Delta Air Lines

$50.89

-0.93 (-1.79%)

JBLU

JetBlue

$17.68

-0.24 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 04

    Mar

10:15
02/20/19
02/20
10:15
02/20/19
10:15
General news
FX Action: USD-CAD »

FX Action: USD-CAD traded…

DWDP

DowDuPont

$55.00

0.4 (0.73%)

10:10
02/20/19
02/20
10:10
02/20/19
10:10
Options
Put buyers in DowDuPont weekly options »

Put buyers in DowDuPont…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 27

    Feb

  • 04

    Mar

  • 04

    Mar

  • 13

    Mar

  • 28

    May

MGNX

MacroGenics

$21.98

-0.2 (-0.90%)

, XNCR

Xencor

$33.00

-3.18 (-8.79%)

10:09
02/20/19
02/20
10:09
02/20/19
10:09
Recommendations
MacroGenics, Xencor analyst commentary  »

Xencor hold supports…

MGNX

MacroGenics

$21.98

-0.2 (-0.90%)

XNCR

Xencor

$33.00

-3.18 (-8.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

MBIO

Mustang Bio

$4.15

(0.00%)

, FBIO

Fortress Biotech

$2.15

-0.01 (-0.46%)

10:05
02/20/19
02/20
10:05
02/20/19
10:05
Recommendations
Mustang Bio, Fortress Biotech analyst commentary  »

Mustang Bio partnership…

MBIO

Mustang Bio

$4.15

(0.00%)

FBIO

Fortress Biotech

$2.15

-0.01 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMB

Trimble

$39.47

0.1 (0.25%)

, DGII

Digi International

$13.40

0.04 (0.30%)

10:03
02/20/19
02/20
10:03
02/20/19
10:03
Hot Stocks
Trimble, Digi collaborate to provide fleets with cold chain compliance solution »

Trimble (TRMB) announced…

TRMB

Trimble

$39.47

0.1 (0.25%)

DGII

Digi International

$13.40

0.04 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 05

    Mar

  • 14

    Mar

WWW

Wolverine World Wide

$35.90

-3.6 (-9.11%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Wolverine World Wide falls -9.1% »

Wolverine World Wide is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

LC

LendingClub

$3.27

-0.355 (-9.81%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
LendingClub falls -10.4% »

LendingClub is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.46

-1.48 (-18.64%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Owens & Minor falls -18.5% »

Owens & Minor is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

NVTA

Invitae

$18.07

1.58 (9.58%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Invitae rises 9.0% »

Invitae is up 9.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.